Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666808 · ClinicalTrials.gov registry record · Phase 2
FACBC Outcomes for Post Prostatectomy
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 165
- Enrollment target
NCT01666808 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 165 participants.
The verdict
NCT01666808, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 165 participants
- Enrollment target
Study Summary
Investigators will perform a study with 162 patients in whom there is a strong suspicion of prostate cancer that has returned to the body after having a prostatectomy. Half of these patients will have radiotherapy decision-making and delivery per the usual routine, and half of these patients will have the radiotherapy decision and volumes guided by the FACBC test (anti-1-amino-3-\[18F\]fluorocyclobutane-1-carboxylic acid (anti-3- \[18F\]FACBC). The major goal of the investigation is to see whether the FACBC improves the selection and the cancer control rates of post-surgery patients with a rising PSA who undergo radiotherapy.
Interventions
- RADIATION Radiation therapy
- DRUG FACBC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2012-09 |
| Est. Completion | 2022-04-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01666808
The ClinicalTrials.gov registry entry for NCT01666808 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation therapy is the first listed.
NCT01666808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01666808 about?
NCT01666808 is a clinical study titled "FACBC Outcomes for Post Prostatectomy". Investigators will perform a study with 162 patients in whom there is a strong suspicion of prostate cancer that has returned to the body after having a prostatectomy. Half of these patients will have radiotherapy decision-making and delivery per the usual routine, and half of these patients will ha...
What is the current status of trial NCT01666808?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 165 participants. The study started on 2012-09. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT01666808?
The interventions under investigation include: Radiation therapy (RADIATION), FACBC (DRUG).
Who is sponsoring clinical trial NCT01666808?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.